SCHEMBL269002

SCHEMBL269002

O=c1c2ccc3c4ccc5c6c(ccc(c7ccc(c2c37)c2nc3ccccc3n12)c46)c(=O)n1c2ccccc2nc51

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.68
KMT2A Q03164 5/20 0.67
MAPT P10636 4/20 0.67
MEN1 O00255 3/20 0.67
CYP1A2 P05177 2/20 0.67
CAMKK1 Q8N5S9 2/20 0.67
CAMKK2 Q96RR4 2/20 0.67
CYP2D6 P10635 1/20 0.67
CYP2C9 P11712 1/20 0.67
CASP1 P29466 1/20 0.67
CYP2C19 P33261 1/20 0.67
CASP7 P55210 1/20 0.67
NPC1 O15118 3/20 0.65
RAB9A P51151 3/20 0.65
CYP3A4 P08684 1/20 0.65
CSNK2A2 P19784 1/20 0.62
CSNK2B P67870 1/20 0.62
CSNK2A1 P68400 1/20 0.62
PIM3 Q86V86 1/20 0.62
DYRK2 Q92630 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7598251 1.00 BCL2 (0.68) BCL2KMT2AMAPTMEN1CYP1A2
SCHEMBL7599458 1.00 BCL2 (0.68) BCL2KMT2AMAPTMEN1CYP1A2
SCHEMBL29363030 1.00 BCL2 (0.68) BCL2KMT2AMAPTMEN1CYP1A2
SCHEMBL7598227 1.00 BCL2 (0.68) BCL2KMT2AMAPTMEN1CYP1A2
SCHEMBL7601022 1.00 BCL2 (0.68) BCL2KMT2AMAPTMEN1CYP1A2
SCHEMBL269440 1.00 BCL2 (0.68) BCL2KMT2AMAPTMEN1CYP1A2
SCHEMBL29357905 1.00 BCL2 (0.68) BCL2KMT2AMAPTMEN1CYP1A2
SCHEMBL29538712 0.98 BCL2 (0.70) BCL2KMT2AMAPTMEN1CYP1A2
SCHEMBL824450 0.98 BCL2 (0.70) BCL2KMT2AMAPTMEN1CYP1A2
SCHEMBL342318 0.98 BCL2 (0.70) BCL2KMT2AMAPTMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 585 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200316370-A1 DEVICE AND METHOD FOR NEUROSTIMULATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2020-10-08 US claimed
EP-1256989-B1 Organic light emitting diode with high contrast ratio EASTMAN KODAK CO (US) 2007-11-14 EP claimed
US-5686213-A ELECTROSTATIC PHOTOCONDUCTOR XEROX CORPORATION (US) 1997-11-11 US claimed
EP-0554110-B1 Processes for the preparation of photogenerating compositions XEROX CORP (US) 1997-05-07 EP claimed
US-5484674-A Benzimidazole perylene imaging members and processes thereof XEROX CORPORATION (US) 1996-01-16 US claimed
US-H1474-H Adding a perylene pigment to a titanyl phthalocyanine charge generating compound to increase cyclic stability and photosensitivity; photoelectrography; xerography; laser printing XEROX CORPORATION 1995-08-01 US claimed
EP-0554110-A1 Processes for the preparation of photogenerating compositions XEROX CORPORATION (US) 1993-08-04 EP claimed
US-5225307-A Sublimation of pelletized photogenerating pigment XEROX CORPORATION (US) 1993-07-06 US claimed
US-20240215290-A1 LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LAB (JP) 2024-06-27 US disclosed
US-20240215290-A1 LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LAB (JP) 2024-06-27 US disclosed
US-20240027927-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJIFILM BUSINESS INNOVATION CORP. (JP) 2024-01-25 US disclosed
US-20240027927-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJIFILM BUSINESS INNOVATION CORP. (JP) 2024-01-25 US disclosed
US-20230333493-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJIFILM BUSINESS INNOVATION CORP. (JP) 2023-10-19 US disclosed
US-11793074-B2 Organic compound and photoelectric conversion element CANON KABUSHIKI KAISHA (JP) 2023-10-17 US disclosed
EP-0554110-B1 Processes for the preparation of photogenerating compositions XEROX CORP (US) 1997-05-07 EP disclosed
US-5484674-A Benzimidazole perylene imaging members and processes thereof XEROX CORPORATION (US) 1996-01-16 US disclosed
US-5384223-A Styrene-vinylpyridine block polymer XEROX CORPORATION (US) 1995-01-24 US disclosed
US-5322755-A Supporting substrate, photogenerator layer of perylene photoconductive pigments dispersed in resin binder mixture of at least two polymers, and charge transport layer XEROX CORPORATION (US) 1994-06-21 US disclosed
EP-0554110-A1 Processes for the preparation of photogenerating compositions XEROX CORPORATION (US) 1993-08-04 EP disclosed
US-5225307-A Sublimation of pelletized photogenerating pigment XEROX CORPORATION (US) 1993-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11793074-B2 Organic compound and photoelectric conversion element CRY1, CYP1A1, CCNE2 BCL2 3851/4885KMT2A 1018/4885MAPT 3569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.